The current diagnosis for Major Depressive disorder (MDD) is dependent on symptomatic clusters and resulting high error rates. The study identifies a panel of biomarkers using 1H NMR spectroscopy and logistic regression prediction modelling. The VIP score of >1.5 and S-plot based on OPLS-DA depicted 4 significant metabolites (phosphocreatine, phosphocholine, glycerophosphocholine and glutamine) indicating abnormalities in energy and lipid metabolism. Phosphocreatine showed the highest AUC of 0.875 with 90% sensitivity and specificity, while with a combination of 4 metabolites, the AUC increased to 0.927 with 96.3% sensitivity and 87.5% specificity, which may act as a supplementary diagnostic tool for MDD.
No takes yet. Share an insight, caveat, or question.
Tyagi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: